Overview
A leading life sciences hub in central London required a dependable and efficient source of liquid nitrogen to support laboratory research applications. Given the site’s central location, traditional LN₂ deliveries were increasingly difficult to schedule and coordinate, with access restrictions adding further complexity.
Our client needed a solution that would eliminate reliance on deliveries, ensure a continuous supply, and reduce operational headaches.
The Challenge
Coordinating tanker deliveries in central London had become both costly and disruptive, with limited access windows making reliable supply unachievable. For a hub supporting essential life sciences research, being vulnerable to supply chain issues and shortages was not a risk they could afford.
The Solution
To address these challenges, the client chose the Titan LN240 skid-mounted liquid nitrogen generator to be installed. The Titan series is designed to provide reliable and continuous LN₂ production, removing the dependency on third-party deliveries.
With its open skid design and 500-litre internal storage capacity, the Titan allows for large-scale dispensing or direct transmission to applications such as NMR, IVF, pharmaceutical research and more.
The Results
The installation delivered immediate benefits to the client:
-
Operational Independence: Eliminated reliance on scheduled LN₂ tanker deliveries, reducing logistical headaches and boil-off losses associated with transportation.
-
Continuous Supply: Guaranteed on-demand availability of liquid nitrogen, crucial for sensitive life sciences applications where any break in the cold chain can lead to compromised samples and irreversible damage.
-
Quiet Operation: The client noted that the plant’s quiet running exceeded their expectations.
Ongoing Support by Noblegen
The client received end-to-end support, from the tender stage through installation and commissioning. With ongoing expert cryogenic service in place, the generator will be maintained to deliver reliable, uninterrupted performance, ensuring vital research in the UK capital continues without disruptions.